ANNA JAMES: Open Payments
NPI 1144839069 · TUSCUMBIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 17 payments from 9 companies in 2025. Trend: 2023 $240 · 2024 $465 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $79 |
| Corcept Therapeutics | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| ABBVIE INC. | 2 | $33 |
| Dexcom, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Korlym, Wegovy, VRAYLAR, BREZTRI, AIRSUPRA, Ozempic, Dexcom G6 Transmitter, VYEPTI.
Industry payments across AL — which companies pay providers there.
